An investigation of severe neonatal hyperbilirubinemia in 13 hospitals of Jiangsu Province, China
LI Qian-Qian1, DONG Xiao-Yue2, QIAO Yu3, YIN Yu-Jie4, GAO Yan5, ZHOU Jin-Jun6, YANG Li7, ZHU Rong-Ping8, WANG Fu-Dong9, WAN Jun10, XU Yan11, PAN Zhao-Jun12, WANG Wei-Yuan13, YAN Jun-Mei1, HAN Shu-Ping2, LU Hong-Yan3, HU Yu-Hua4, LI Shuang-Shuang6, WANG Jin-Xiu8, WU Ming-Fu9, WANG Jun11, DENG Xiao-Yi1, YU Zhang-Bin2
Department of Pediatrics, Maternity Hospital, Nanjing Medical University, Nanjing 210004, China
Abstract：Objective To investigate the incidence of severe neonatal hyperbilirubinemia and the management on the treatment and follow-up of this disease in Jiangsu Province, China. Methods The neonates with severe hyperbilirubinemia who were admitted to 13 hospitals in Jiangsu Province from January to December, 2018, were enrolled as subjects. A retrospective analysis was performed on their mediacal data and follow-up data. Results In 2018, 740 neonates with severe hyperbilirubinemia were reported from the 13 hospitals in Jiangsu Province, accounting for 2.70% (740/27 386) of the total number of neonates admitted to the department of neonatology. Among these neonates, 620 (83.8%) had severe hyperbilirubinemia, 106 (14.3%) had extremely severe hyperbilirubinemia, and 14 (1.9%) had hazardous hyperbilirubinemia. Four neonates (0.5%) were diagnosed with acute bilirubin encephalopathy. A total of 484 neonates (65.4%) were readmitted due to severe hyperbilirubinemia after discharge from the delivery institution, with a median age of 7 days, among whom 214 (44.2%) were followed up for jaundice at the outpatient service before readmission, with a median age of 6 days at the first time of outpatient examination. During hospitalization, 211 neonates (28.5%) underwent cranial MRI examinations, among whom 85 (40.3%) had high T1WI signal in the bilateral basal ganglia and the globus pallidus; 238 neonates (32.2%) underwent brainstem auditory evoked potential examinations, among whom 14 (5.9%) passed only at one side and 7 (2.9%) failed at both sides. The 17 neonates with acute bilirubin encephalopathy or hazardous hyperbilirubinemia were followed up. Except one neonate was lost to follow-up, and there were no abnormal neurological symptoms in the other neonates. Conclusions Neonates with severe hyperbilirubinemia account for a relatively high proportion of the total number of neonates in the department of neonatology. Jaundice monitoring and management after discharge from delivery institutions need to be strengthened. For neonates with severe hyperbilirubinemia, relevant examinations should be carried out more comprehensively during hospitalization and these neonates should be followed up comprehensively and systematically after discharge.
LI Qian-Qian,DONG Xiao-Yue,QIAO Yu et al. An investigation of severe neonatal hyperbilirubinemia in 13 hospitals of Jiangsu Province, China[J]. CJCP, 2020, 22(7): 690-695.
Olusanya BO, Kaplan M, Hansen TWR. Neonatal hyperbilirubinaemia:a global perspective[J]. Lancet Child Adolesc Health, 2018, 2(8):610-620.
[2]
Olusanya BO, Ogunlesi TA, Kumar P, et al. Management of late-preterm and term infants with hyperbilirubinaemia in resource-constrained settings[J]. BMC Pediatr, 2015, 15:39.
[3]
Greco C, Arnolda G, Boo NY, et al. Neonatal jaundice in low-and middle-income countries:lessons and future directions from the 2015 Don Ostrow Trieste Yellow Retreat[J]. Neonatology, 2016, 110(3):172-180.
[4]
Christensen RD, Agarwal AM, George TI, et al. Acute neonatal bilirubin encephalopathy in the State of Utah 2009-2018[J]. Blood Cells Mol Dis, 2018, 72:10-13.
[5]
Pratesi S, Dani C, Raimondi F, et al. The Italian Registry of kernicterus and hyperbilirubinaemia[J]. J Matern Fetal Neonatal Med, 2012, 25(Suppl 4):118-120.
[6]
Diala UM, Wennberg RP, Abdulkadir I, et al. Patterns of acute bilirubin encephalopathy in Nigeria:a multicenter pre-intervention study[J]. J Perinatol, 2018, 38(7):873-880.
[7]
Johnson L, Bhutani VK, Karp K, et al. Clinical report from the pilot USA Kernicterus Registry (1992 to 2004)[J]. J Perinatol, 2009, 29(Suppl 1):S25-S45.
[8]
Erdeve O, Okulu E, Olukman O, et al. The Turkish neonatal jaundice online registry:a national root cause analysis[J]. PLoS One, 2018, 13(2):e0193108.
[9]
Bhutani VK, Johnson L. Synopsis report from the pilot USA Kernicterus Registry[J]. J Perinatol, 2009, 29(Suppl 1):S4-S7.
[10]
Alkén J, Håkansson S, Ekéus C, et al. Rates of extreme neonatal hyperbilirubinemia and kernicterus in children and adherence to national guidelines for screening, diagnosis, and treatment in Sweden[J]. JAMA Netw Open, 2019, 2(3):e190858.
American Academy of Pediatrics Subcommittee on Hyperbilirubinemia. Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation[J]. Pediatrics, 2004, 114(1):297-316.
Sgro M, Kandasamy S, Shah V, et al. Severe neonatal hyperbilirubinemia decreased after the 2007 Canadian guidelines[J]. J Pediatr, 2016, 171:43-47.
[15]
Olusanya BO, Teeple S, Kassebaum NJ. The contribution of neonatal jaundice to global child mortality:findings from the GBD 2016 study[J]. Pediatrics, 2018, 141(2):e20171471.
[16]
GBD 2016 Causes of Death Collaborators. Global, regional, and national age-sex specific mortality for 264 causes of death, 1980-2016:a systematic analysis for the Global Burden of Disease Study 2016[J]. Lancet, 2017, 390(10100):1151-1210.
[17]
Burgos AE, Flaherman VJ, Newman TB. Screening and follow-up for neonatal hyperbilirubinemia:a review[J]. Clin Pediatr (Phila), 2012, 51(1):7-16.
[18]
Han S, Yu Z, Liu L, et al. A model for predicting significant hyperbilirubinemia in neonates from China[J]. Pediatrics, 2015, 136(4):e896-e905.
Mreihil K, Nakstad B, Stensvold HJ, et al. Uniform national guidelines do not prevent wide variations in the clinical application of phototherapy for neonatal jaundice[J]. Acta Paediatr, 2018, 107(4):620-627.
[21]
Lee BK, Le Ray I, Sun JY, et al. Haemolytic and nonhaemolytic neonatal jaundice have different risk factor profiles[J]. Acta Paediatr, 2016, 105(12):1444-1450.
